Janice Troha, Executive Vice President / COO at Nivalis Therapeutics, Inc. (NVLS), bought 10,000 shares at $2.34 ($23K) on 2017-05-05, disclosed to the SEC on 2017-05-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.